The University of Kansas Medical Center
The University of Kansas Medical Center
North Kansas City, Missouri, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers | Advanced Biliary Tract Cancer | Active, not recruiting | Phase 1 / Phase 2 | 2026-01-23 | NCT04781192 |